BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]
Type:  Journal Contribution

Results 21-40 of 57 (Search time: 0.043 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
212016Adaptive Randomization of Neratinib in Early Breast CancerBUYSE, Marc; Saad, E.; BURZYKOWSKI, TomaszJournal ContributionA1
222016Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancerMichiels, Stefan; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; BUYSE, Marc; Piccart, M.Journal ContributionA1
232016Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group TrialTimmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
242016Neoadjuvant as Future for Drug Development in Breast Cancer-LetterBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA1
252016Statistical evaluation of surrogate endpoints with examples from cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszJournal ContributionA1
262016Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'Saad, E. D.; BUYSE, MarcJournal ContributionA1
272016The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical TrialsPeron, Julien; Roy, Pascal; Ozenne, Brice; Roche, Laurent; BUYSE, MarcJournal ContributionA1
282016Data Sharing - Is the Juice Worth the Squeeze?Strom, Brian L.; BUYSE, Marc; Hughes, John; Knoppers, Bartha M.Journal ContributionA1
292016Neratinib after trastuzumab in patients with HER2-positive breast cancer ReplyChan, Arlene; BUYSE, Marc; Yao, BinJournal ContributionA1
302016Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agentsSaad, E. D.; BUYSE, MarcJournal ContributionA1
312016Fraud in clinical trials: complex problem, simple solutions?Sakamoto, Junichi; BUYSE, MarcJournal ContributionA2
322015On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
332015Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkersZhao, Lili; Feng, Dai; Neelon, Brian; BUYSE, MarcJournal ContributionA1
342015Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancerCiani, Oriana; BUYSE, Marc; Garside, Ruth; Peters, Jaime; Saad, Everardo D.; Stein, Ken; Taylor, Rod S.Journal ContributionA1
352015Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid LeukemiaSchlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionM
362014Data Sharing, Year 1 - Access to Data from Industry-Sponsored Clinical TrialsStrom, Brian L.; BUYSE, Marc; Hughes, John; Knoppers, Bartha M.Journal ContributionA2
372014Linear mixed-effects models for central statistical monitoring of multicenter clinical trialsDesmet, L.; Venet, D.; Doffagne, E.; Timmermans, C.; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
382013Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used?MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
392013Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trialsLaporte, Silvy; Squifflet, Pierre; Baroux, Noemie; Fossella, Frank; Georgoulias, Vassilis; Pujol, Jean-Louis; Douillard, Jean-Yves; Kudoh, Shinzohy; Pignon, Jean-Pierre; Quinaux, Emmanuel; BUYSE, MarcJournal ContributionA1
402013Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-AnalysisOba, Koji; PAOLETTI, Xavier; Alberts, Steven; Bang, Yung-Jue; Benedetti, Jacqueline; Bleiberg, Harry; CATALANO, Paul; Lordick, Florian; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-pierre; Rougier, Philippe; Sasako, Mitsuru; Sakamoto, Junichi; Sargent, Daniel; Shitara, Kohei; Cutsem, Eric Van; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
show all